Figure legends
Figure 1: Study design. Patients of the intervention group
befenited from a pharmaceutical intervention the day of the inclusion
(D0; day 0). Both groups had a follow-up consultation three months (M3)
after the inclusion, and control group benefited from a pharmaceutical
intervention after the follow-up consultation.
Figure 2: Number of inclusion and lost to follow-up